CIK 1807489
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 96.61% | 7 |
| Unclassified | 1.81% | 1 |
| Health Care Equipment & Supplies | 1.58% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | WVE | Wave Life Sciences Ltd. | Health Care | 61.83% |
| 2 | IVVD | Invivyd, Inc. | Health Care | 22.35% |
| 3 | TGTX | TG THERAPEUTICS, INC. | Health Care | 5.46% |
| 4 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Health Care | 4.29% |
| 5 | PRQR | PROQR THRAPEUTICS N V | Unclassified | 1.81% |
| 6 | GUTS | FRACTYL HEALTH, INC. | Health Care | 1.58% |
| 7 | RCKT | ROCKET PHARMACEUTICALS, INC. | Health Care | 1.40% |
| 8 | SLN | Silence Therapeutics plc | Health Care | 0.99% |
| 9 | CRIS | CURIS INC | Health Care | 0.29% |
8/9 names classified · sector 98.2% of weight · industry 98.2% · mkt cap 98.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 98.2% of the book is sector-classified (unclassified names shown, never dropped).
Only 5% of book weight classified — the grid is NOT representative of the whole book.
Classified: 5.5% of book weight (1/9 names) · unclassified 94.5%: WVE, IVVD, ARWR, PRQR, GUTS, RCKT, SLN, CRIS. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 4,588,284 | $33M | 61.8% | TRIM −19% |
| 2 | IVVDINVIVYD INC | 9,248,250 | $12M | 22.3% | HOLD |
| 3 | TGTXTG THERAPEUTICS INC | 88,354 | $3M | 5.5% | TRIM −45% |
| 4 | ARWRARROWHEAD PHARMACEUTICALS IN | 36,851 | $2M | 4.3% | TRIM −45% |
| 5 | PRQRPROQR THRAPEUTICS N V | 599,793 | $971,665 | 1.8% | TRIM −41% |
| 6 | GUTSFRACTYL HEALTH INC | 1,856,117 | $849,730 | 1.6% | HOLD |
| 7 | RCKTROCKET PHARMACEUTICALS INC | 210,871 | $754,918 | 1.4% | TRIM −45% |
| 8 | SLNSILENCE THERAPEUTICS PLC | 101,203 | $533,340 | 1.0% | TRIM −45% |
| 9 | CRISCURIS INC | 284,889 | $155,920 | 0.3% | TRIM −45% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| WVEWAVE LIFE SCIENCES LTD | 5.7M | 5.7M | 5.7M | 5.7M | 5.7M | 4.6M | $33M |
| IVVDINVIVYD INC | 9.2M | 9.2M | 9.2M | 9.2M | 9.2M | 9.2M | $12M |
| TGTXTG THERAPEUTICS INC | 162K | 162K | 162K | 162K | 162K | 88K | $3M |
| ARWRARROWHEAD PHARMACEUTICALS IN | 67K | 67K | 67K | 67K | 67K | 37K | $2M |
| PRQRPROQR THRAPEUTICS N V | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 600K | $971,665 |
| GUTSFRACTYL HEALTH INC | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | $849,730 |
| RCKTROCKET PHARMACEUTICALS INC | 386K | 386K | 386K | 386K | 386K | 211K | $754,918 |
| SLNSILENCE THERAPEUTICS PLC | 185K | 185K | 185K | 185K | 185K | 101K | $533,340 |
| CRISCURIS INC | 521K | 521K | 521K | 521K | 521K | 285K | $155,920 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
